These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 33691550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
    Hu B, Tian X, Sun J, Meng X.
    Int J Mol Sci; 2013 Dec 02; 14(12):23559-80. PubMed ID: 24317431
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis.
    Wang X, Zhang Y, Yang N, He H, Tao X, Kou C, Jiang J.
    Biomed Res Int; 2020 Dec 02; 2020():5087643. PubMed ID: 33015170
    [Abstract] [Full Text] [Related]

  • 4. Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.
    Kim SU, Park JH, Kim HS, Lee JM, Lee HG, Kim H, Choi SH, Baek S, Kim BK, Park JY, Kim DY, Ahn SH, Lee JD, Han KH.
    Yonsei Med J; 2015 Sep 02; 56(5):1296-306. PubMed ID: 26256972
    [Abstract] [Full Text] [Related]

  • 5. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.
    Yamamoto K, Imamura H, Matsuyama Y, Kume Y, Ikeda H, Norman GL, Shums Z, Aoki T, Hasegawa K, Beck Y, Sugawara Y, Kokudo N.
    J Gastroenterol; 2010 Dec 02; 45(12):1272-82. PubMed ID: 20625772
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
    Jang ES, Jeong SH, Kim JW, Choi YS, Leissner P, Brechot C.
    PLoS One; 2016 Dec 02; 11(3):e0151069. PubMed ID: 26986465
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ.
    World J Gastroenterol; 2013 Jan 21; 19(3):339-46. PubMed ID: 23372355
    [Abstract] [Full Text] [Related]

  • 8. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
    Hadziyannis E, Sialevris K, Georgiou A, Koskinas J.
    Oncol Rep; 2013 Feb 21; 29(2):835-9. PubMed ID: 23174906
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
    Xu WJ, Guo BL, Han YG, Shi L, Ma WS.
    Tumour Biol; 2014 Dec 21; 35(12):12069-74. PubMed ID: 25209179
    [Abstract] [Full Text] [Related]

  • 10. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
    Zhao Y, Wang M, Cui C, Zhang L, Liao F, Li H, Wu X.
    Cancer Biomark; 2015 Dec 21; 15(5):677-83. PubMed ID: 26406957
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
    Dai M, Chen X, Liu X, Peng Z, Meng J, Dai S.
    PLoS One; 2015 Dec 21; 10(10):e0140067. PubMed ID: 26441340
    [Abstract] [Full Text] [Related]

  • 12. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
    Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M.
    Gastroenterology; 2009 Jul 21; 137(1):110-8. PubMed ID: 19362088
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.
    Volk ML, Hernandez JC, Su GL, Lok AS, Marrero JA.
    Cancer Biomark; 2007 Jul 21; 3(2):79-87. PubMed ID: 17522429
    [Abstract] [Full Text] [Related]

  • 14. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
    Zhou Y, Yin X, Ying J, Zhang B.
    BMC Cancer; 2012 Jan 16; 12():17. PubMed ID: 22244200
    [Abstract] [Full Text] [Related]

  • 15. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma.
    Choi J, Kim GA, Han S, Lee W, Chun S, Lim YS.
    Hepatology; 2019 May 16; 69(5):1983-1994. PubMed ID: 30153338
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, Takasaki K, Nakano M.
    J Gastroenterol Hepatol; 2002 Jul 16; 17(7):772-8. PubMed ID: 12121507
    [Abstract] [Full Text] [Related]

  • 17. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma.
    Pang BY, Leng Y, Wang X, Wang YQ, Jiang LH.
    Ann Med; 2023 Dec 16; 55(1):42-61. PubMed ID: 36476015
    [Abstract] [Full Text] [Related]

  • 18. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
    Sassa T, Kumada T, Nakano S, Uematsu T.
    Eur J Gastroenterol Hepatol; 1999 Dec 16; 11(12):1387-92. PubMed ID: 10654799
    [Abstract] [Full Text] [Related]

  • 19. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
    Yi X, Yu S, Bao Y.
    Clin Chim Acta; 2013 Oct 21; 425():212-20. PubMed ID: 23954771
    [Abstract] [Full Text] [Related]

  • 20. Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.
    Morimoto M, Numata K, Nozaki A, Kondo M, Moriya S, Taguri M, Morita S, Konno M, Sugo A, Miyajima E, Maeda S, Tanaka K.
    Int J Clin Oncol; 2012 Aug 21; 17(4):373-9. PubMed ID: 21847534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.